Swiss pharma companies eye follow up to Pfizer-US pricing deal, business lobby says
GENEVA (Reuters) -Swiss pharma companies are likely to follow Pfizer's price deal with the U.S. foll...
1st October, 2025
Covering equities, fixed income, derivatives, foreign exchange and macro‑economic policy, the Finance section draws on Global Banking & Finance Review’s market analysis and investment coverage. Articles provide data‑driven insights and strategies for investors, analysts and policymakers.
GENEVA (Reuters) -Swiss pharma companies are likely to follow Pfizer's price deal with the U.S. foll...
1st October, 2025

LONDON (Reuters) -Britain's government on Wednesday won its lawsuit against a firm at the centre of...
1st October, 2025
LONDON (Reuters) -Euro zone manufacturing activity slipped back into contraction in September as new...
1st October, 2025
AMSTERDAM (Reuters) -Dutch pension fund ABP has sold its entire stake in U.S. construction equipment...
1st October, 2025
PARIS (Reuters) -French supermarket group Casino and its former chief executive, Jean-Charles Naouri...
1st October, 2025
(Reuters) -London's FTSE 100 reached a fresh intraday peak on Wednesday, propelled by gains in the h...
1st October, 2025

LONDON (Reuters) -Bank of England Governor Andrew Bailey said on Wednesday that any stablecoin that...
1st October, 2025
MILAN (Reuters) -Saipem does not see regulatory risks for its planned merger with Norwegian rival Su...
1st October, 2025

By Ilona Wissenbach BERLIN (Reuters) -ZF Friedrichshafen will cut around a quarter of its workforce...
1st October, 2025
MOSCOW (Reuters) -The Kremlin warned European leaders on Wednesday that Russia would pursue any indi...
1st October, 2025
By Virginia Furness and Kate Abnett LONDON (Reuters) -Investors representing more than 4.5 trillion...
1st October, 2025
By Dhara Ranasinghe and Koh Gui Qing NEW YORK/LONDON (Reuters) -Caution took hold of world markets o...
1st October, 2025